For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
SEMAGLUTIDE: products 1 to 13 of 13.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Semaglutide Injection 0.68mg/mL Inj Sol - Pref Pen 3mL PkDIN 02568020 | Limited Use, codes 667 | $78.1410per source unit | Requirements & sourcesBuild cost plan |
| Apo-Semaglutide Injection 1.34mg/mL Inj Sol-Pref Pen 3mL PkDIN 02568012 | Limited Use, codes 665 | $78.1410per source unit | Requirements & sourcesBuild cost plan |
| Ozempic 0.68mg/mL Inj Sol - Pref Pen 3mL PkDIN 02540258 | Limited Use, codes 667 | $78.1410per source unit | Requirements & sourcesBuild cost plan |
| Ozempic 1.34mg/mL Inj Sol-Pref Pen 1.5mL PkDIN 02471477 | Limited Use, codes 666 | $78.1410per source unit | Requirements & sourcesBuild cost plan |
| Ozempic 1.34mg/mL Inj Sol-Pref Pen 3mL PkDIN 02471469 | Limited Use, codes 665 | $78.1410per source unit | Requirements & sourcesBuild cost plan |
| Rybelsus 1.5mg TabDIN 02551012 | Limited Use, codes 738 | $7.5303per source unit | Requirements & sourcesBuild cost plan |
| Rybelsus 14mg TabDIN 02497611 | Limited Use, codes 664 | $7.5303per source unit | Requirements & sourcesBuild cost plan |
| Rybelsus 3mg TabDIN 02497581 | Limited Use, codes 662 | $7.5303per source unit | Requirements & sourcesBuild cost plan |
| Rybelsus 4mg TabDIN 02551020 | Limited Use, codes 739 | $7.5303per source unit | Requirements & sourcesBuild cost plan |
| Rybelsus 7mg TabDIN 02497603 | Limited Use, codes 663 | $7.5303per source unit | Requirements & sourcesBuild cost plan |
| Rybelsus 9mg TabDIN 02551039 | Limited Use, codes 740 | $7.5303per source unit | Requirements & sourcesBuild cost plan |
| Semaglutide Injection 1.34mg/mL Inj Sol-Pref Pen 1.5mL PkDIN 02567806 | Limited Use, codes 666 | $78.1410per source unit | Requirements & sourcesBuild cost plan |
| Semaglutide Injection 1.34mg/mL Inj Sol-Pref Pen 3mL PkDIN 02567814 | Limited Use, codes 665 | $78.1410per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives